The Effectiveness of a Pressure Ulcer Prevention Programme for Older People in For-profit Private Nursing Homes
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Oct 18, 2014
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
The study will be conducted as a two-arm cluster randomized controlled trial, which will compare the efficacy of a PU prevention programme versus usual PU prevention for older people in eight for-profit private nursing homes in Hong Kong. For-profit private NHs recruited will be randomly assigned as experimental or control groups. The nursing homes in the experimental group will be implemented a PU prevention programme. The programme includes a training course which was tailor-made for health workers(HWs) and persona care workers (PCWs) and also a 16-week PU prevention protocol. The outcome...
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- • For-profit private nursing homes having been classified as the category A2 homes in the Enhanced Bought Place Scheme and are eager to improve current pressure ulcer prevention care;
- • For for-profit private nursing homes having a capacity of around 130-150 beds;
- • For for-profit private nursing homes having no structured PU prevention protocol, and/or programmes in place;- Residents aged 60 or above
- • Care staff including personal care workers, health workers and nurses who provide direct care to residents.
- Exclusion Criteria:
- • Care staffs who are not speak in Chinese.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Trial Officials
Enid Kwong, PhD
Principal Investigator
Tung Wah College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials